Tag: De-scheduling
Key DEA Change Could Make Cannabinoid-Based Medicine More Accessible
Washington D.C. – The Drug Enforcement Administration (DEA) is making policy changes that could make it easier for patients to access Epidiolex.
Epidiolex, produced...
